Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2015 1
2016 1
2017 1
2019 3
2020 5
2021 3
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1.
Luangwattananun P, Sangsuwannukul T, Supimon K, Thuwajit C, Chieochansin T, Sa-Nguanraksa D, Samarnthai N, O-Charoenrat P, Junking M, Yenchitsomanus PT. Luangwattananun P, et al. Among authors: sa nguanraksa d. Int Immunopharmacol. 2023 Nov;124(Pt B):111012. doi: 10.1016/j.intimp.2023.111012. Epub 2023 Oct 5. Int Immunopharmacol. 2023. PMID: 37804657
Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer.
Thongchot S, Jirapongwattana N, Luangwattananun P, Chiraphapphaiboon W, Chuangchot N, Sa-Nguanraksa D, O-Charoenrat P, Thuwajit P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: sa nguanraksa d. Mol Cancer Ther. 2022 May 4;21(5):727-739. doi: 10.1158/1535-7163.MCT-21-0823. Mol Cancer Ther. 2022. PMID: 35313339 Free PMC article.
Gail Model Underestimates Breast Cancer Risk in Thai Population.
Sa-Nguanraksa D, Sasanakietkul T, O-Charoenrat C, Kulprom A, O-Charoenrat P. Sa-Nguanraksa D, et al. Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2385-2389. doi: 10.31557/APJCP.2019.20.8.2385. Asian Pac J Cancer Prev. 2019. PMID: 31450910 Free PMC article.
Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines.
Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C. Thongchot S, et al. Among authors: sa nguanraksa d. Oncol Rep. 2021 Dec;46(6):254. doi: 10.3892/or.2021.8205. Epub 2021 Oct 15. Oncol Rep. 2021. PMID: 34651665 Free PMC article.
Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells.
Jirapongwattana N, Thongchot S, Chiraphapphaiboon W, Chieochansin T, Sa-Nguanraksa D, Warnnissorn M, Thuwajit P, Yenchitsomanus PT, Thuwajit C. Jirapongwattana N, et al. Among authors: sa nguanraksa d. Oncol Rep. 2022 Jul;48(1):127. doi: 10.3892/or.2022.8338. Epub 2022 May 26. Oncol Rep. 2022. PMID: 35616135 Free PMC article.
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.
Suntiparpluacha M, Chanthercrob J, Sa-Nguanraksa D, Sitthikornpaiboon J, Chaiboonchoe A, Kueanjinda P, Jinawath N, Sampattavanich S. Suntiparpluacha M, et al. Among authors: sa nguanraksa d. PeerJ. 2023 Jun 12;11:e15350. doi: 10.7717/peerj.15350. eCollection 2023. PeerJ. 2023. PMID: 37334114 Free PMC article.
22 results